NISCH
MOLECULAR TARGETnischarin
NISCH (nischarin) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NISCH
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Clonidine | 2.40 | 10 |
| 2 | Rilmenidine Oxazole derivative that acts as | 2.08 | 7 |
| 3 | Idazoxan | 1.79 | 5 |
| 4 | Naphazoline | 1.39 | 3 |
| 5 | Guanabenz | 1.10 | 2 |
| 6 | Oxymetazoline | 1.10 | 2 |
| 7 | Guanfacine | 0.69 | 1 |
| 8 | Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is | 0.69 | 1 |
| 9 | Mescaline Hallucinogenic alkaloid isolated from | 0.69 | 1 |
| 10 | Phentolamine | 0.69 | 1 |
About NISCH as a Drug Target
NISCH (nischarin) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented NISCH interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NISCH inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.